Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
November 20th, 2018
6K views
Here, we present a protocol to obtain 68Ga core-doped iron oxide nanoparticles via fast microwave-driven synthesis. The methodology renders PET/(T1)MRI nanoparticles with radiolabeling efficiencies higher than 90% and radiochemical purity of 99% in a 20-min synthesis.
Overview
This study presents a fast microwave-driven synthesis method for producing gallium-68 core-doped iron oxide nanoparticles, designed for hybrid PET/MR molecular imaging. The technique achieves high radiolabeling efficiencies exceeding 90% and maintains a radiochemical purity of 99% within a 20-minute synthesis time.
Key Study Components
Research Area
- Nanoparticle synthesis
- Molecular imaging
- Hybrid imaging techniques
Background
- Importance of radiolabeled nanoparticles in diagnostics
- Challenges in nanoparticle synthesis speed and reproducibility
- Advancements in imaging technologies
Methods Used
- Microwave-driven synthesis protocol
- Iron chloride hexahydrate as the primary material
- Dynamic light scattering for characterizing nanoparticles
Main Results
- Successfully synthesized nanoparticles with a mean hydrodynamic size of 7.9 nanometers
- Demonstrated the stability of nanoparticles in various buffers and serums
- Achieved reproducible results across multiple syntheses
Conclusions
- This method establishes a reliable framework for producing gallium-68 nanoparticles for targeted molecular imaging.
- The study enhances the potential for hybrid imaging applications in oncology and cardiovascular disease research.
Frequently Asked Questions
What are gallium-68 core-doped nanoparticles used for?
They are utilized in hybrid PET/MR molecular imaging for disease diagnostics.
How does microwave technology improve synthesis?
It enables faster and more reproducible synthesis of nanoparticles.
What characterizes the nanoparticles synthesized?
They exhibit a mean hydrodynamic size of 7.9 nanometers and show excellent stability.
What precautions are necessary when handling these materials?
Radioprotection precautions must be observed due to the radioactive nature of gallium-68.
How efficient is the radiolabeling process?
The process achieves radiolabeling efficiencies higher than 90% with a radiochemical purity of 99%.
What other areas could benefit from this synthesis technique?
Research in oncology and cardiovascular diseases could greatly benefit from this technique.
What methods are used to assess nanoparticle stability?
Dynamic light scattering and incubation in various buffers are employed to evaluate stability.
Executive Industry Relevance
This microwave-driven synthesis enables rapid, reproducible production of gallium-68 core-doped iron oxide nanoparticles for dual PET/MR imaging, addressing the need for efficient radiotracer generation in preclinical oncology and cardiovascular research. The method supports high radiolabeling yield (>90%) and favorable T1-weighted MRI contrast properties, facilitating mechanistic de-risking of hybrid imaging probes. By providing a scalable, single-purification workflow, it enhances translational confidence in multi-modal tracer development pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of biodistribution and target engagement through dual-modality PET/MR signal correlation.
- Operational Value: Fast synthesis (<20 min) supports iterative probe optimization in lead identification campaigns.
Screening & Assay Development
- Scientific Value: Produces nanoparticles with defined hydrodynamic size (~7.9 nm) and high r1 relaxivity (11.9 mM−1·s−1) for standardized MRI signal quantification.
- Operational Value: Reproducible radiolabeling yield across syntheses ensures consistent input for receptor binding or pharmacokinetic assays.
Translational & Preclinical Research
- Scientific Value: Demonstrated colloidal stability in serum and buffers supports in vivo imaging studies without significant aggregation or size shift.
- Operational Value: Single gel filtration purification step delivers in vivo-ready material, reducing processing time and variability.
Pipeline & Workflow Integration
This method fits within the early discovery to preclinical continuum, enabling rapid generation of imaging probes for target validation and pharmacokinetic profiling prior to lead optimization.
- Discovery Biology: Facilitates hypothesis testing via dual-modality imaging to clarify biodistribution and target specificity in disease models.
- Screening: Delivers standardized nanoparticle batches with quantifiable MRI and PET outputs for comparative probe evaluation.
- Analytics: Provides measurable hydrodynamic size, relaxivity values, and radiolabeling efficiency as key QC parameters for go/no-go decisions.
- Translational Research: Supports continuity from synthesis to in vivo imaging through demonstrated stability and purification efficiency.
- Enterprise Reuse: Microwave protocol allows platform reuse across different radionuclides or core materials for multi-target imaging programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in tracer behavior through dual-modality signal alignment and low r2/r1 ratio enabling true T1 contrast.
- Operational Value: Standardized, fast synthesis reduces batch failure risk and supports high-throughput probe generation.
- Strategic Value: Enables earlier go/no-go decisions by providing reliable pharmacokinetic and biodistribution data in relevant disease models.
- Portfolio Impact: Risk-adjusted prioritization of imaging agents based on reproducible synthesis and favorable safety/stability profiles.
Implementation Considerations
- Requires expertise in radiochemistry and microwave-assisted synthesis protocols.
- Needs access to a calibrated microwave reactor with precise temperature, pressure, and power control.
- Demands standardized purification and QC procedures (e.g., gel filtration, DLS, radiotLC) across teams.
- Must account for radionuclide decay (68Ga t1/2 = 68 min) in synthesis timing and QC scheduling.
- Limited to lab-scale production; not suited for GMP manufacturing without further adaptation.
Biopharma FAQs
Why does radiolabeling yield matter for target validation studies?
High radiolabeling yield (>90%) ensures sufficient signal intensity for detecting target-specific accumulation in PET imaging, reducing false negatives in biodistribution studies. Consistent yield across syntheses supports reproducible quantification of target engagement in preclinical models.
How does microwave technology improve reproducibility in nanoparticle synthesis?
Microwave heating enables rapid and uniform thermal transfer, producing nanoparticles with narrow size distribution (core size ~4.2 nm) and consistent hydrodynamic size (~7.9 nm) across multiple batches. This minimizes variability in MRI relaxivity and PET signal generation.
What quantitative measurements enable comparative probe assessment?
Hydrodynamic size via DLS, longitudinal relaxivity (r1 = 11.9 mM−1·s−1), and radiolabeling efficiency provide objective metrics to compare probe batches and assess synthesis consistency. These values support data-driven decisions in probe selection for in vivo studies.
Why do replication requirements matter for cross-functional collaboration?
Demonstrated reproducibility across five syntheses ensures that chemistry, imaging, and pharmacology teams receive comparable material, reducing interpretation discrepancies in hybrid imaging data. Standardized protocols allow seamless technology transfer between discovery and preclinical groups.
What statistical analysis capabilities are required before implementation?
Teams must be able to assess nanoparticle size distribution (via DLS), compare relaxivity values, and calculate radiolabeling yield from radioactivity measurements to confirm batch consistency. Basic radiochemical QC (e.g., radio-TLC, gel fractionation) is essential to verify purity and nanoparticle integrity prior to in vivo use.
Chapters in this video
0:04
Title
0:26
Synthesis of Citrate-Coated Iron Oxide Nanoparticles
1:41
Synthesis of 68Ga Core-Doped Iron Oxide Nanoparticles (68Ga-C-IONP)
3:19
Analysis of 68Ga Core-Doped Iron Oxide Nanoparticles (68Ga-C-IONP)
4:42
Results: Characterization of 68Ga Core-Doped Iron Oxide Nanoparticles
6:40
Conclusion
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg%3Fv%3D2026-08-11T08%253A27%253A24.167Z&w=384&q=75)
